Losartan Potassium Active Pharmaceutical Ingredient (API) Market Size and Demand Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the losartan potassium active pharmaceutical ingredient (api) market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The losartan potassium active pharmaceutical ingredient (api) market has experienced significant growth in its size over recent years. This market is anticipated to expand from $1.85 billion in 2025 to $1.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion has been driven by factors such as the increasing prevalence of hypertension, the expiry of branded drug patents, the rise of generic pharmaceutical production, greater demand for cardiovascular medications, and the broadening of global pharmaceutical supply chains.
The losartan potassium active pharmaceutical ingredient (API) market size is anticipated to experience robust expansion over the coming years, projected to reach $2.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is primarily fueled by the increasing prevalence of cardiovascular diseases, a surging demand from emerging markets, ongoing advancements in API manufacturing technologies, a heightened focus on sustainable pharmaceutical production practices, and the broader application in chronic kidney disease treatment. Concurrently, major trends expected in the forecast period include a growing demand for generic losartan formulations, the increasing adoption of continuous flow API manufacturing, a stronger emphasis on cost-efficient antihypertensive APIs, the expanded utilization of losartan API in combination therapies, and an intensified focus on regulatory-compliant API production.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp
Which Drivers Are Supporting The Rise Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The escalating prevalence of hypertension is projected to drive the growth of the losartan potassium active pharmaceutical ingredient (API) market in the coming years. Hypertension signifies a state of persistently high blood pressure, which elevates the potential for heart disease, stroke, and other critical health complications. The rising incidence of hypertension is connected to diets abundant in salt and processed foods, contributing to fluid retention and increased strain on the heart. Losartan potassium aids in controlling hypertension by blocking angiotensin II, a hormone known to narrow blood vessels. This mechanism helps vessels relax and widen, subsequently lowering blood pressure and reducing the heart’s workload. For instance, in September 2025, according to the World Health Organization (WHO), a Geneva, Switzerland-based global health authority, approximately 1.4 billion adults aged 30–79 years had hypertension in 2024, compared with about 1.3 billion adults in 2022. Thus, the increasing prevalence of hypertension is fueling the expansion of the losartan potassium active pharmaceutical ingredient (API) market.
What Leading Segments Are Studied In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –
1) By Product Type: Tablet, Capsule, Other Product Types
2) By Production Method: Synthetic Route, Continuous Flow Production
3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications
5) By End-User: Hospitals, Clinics, Pharmaceutical Companies
Subsegments:
1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets
2) By Capsule: Hard Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates
What Industry Trends Are Transforming The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?
Leading companies in the losartan potassium active pharmaceutical ingredient (API) market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to enhance patient compliance and broaden therapeutic applications. Losartan potassium oral suspension represents a liquid form of the losartan potassium medication, intended for individuals who experience difficulty swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, obtained Food and Drug Administration (FDA) approval for Arbli. Arbli is a ready-to-use liquid formulation designed for hypertension, reducing the risk of stroke in hypertensive patients with left ventricular hypertrophy, and treating diabetic nephropathy in type 2 diabetes patients. It facilitates precise dosing without requiring compounding and is offered in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life when stored at room temperature.
Which Leading Companies Dominate The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Share?
Major companies operating in the losartan potassium active pharmaceutical ingredient (api) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP
Access The Complete Report For Deeper Market Insights:
How Does The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Perform Across Major Global Regions?
North America was the largest region in the losartan potassium API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (api) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Losartan Potassium Active Pharmaceutical Ingredient (API) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp
Browse Through More Reports Similar to the Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market 2026, By The Business Research Company
Active Pharmaceutical Ingredients Market Report 2026
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
